Who invested in Corridor Pharmaceuticals?
Corridor Pharmaceuticals's investors include Quaker Partners, MedImmune Ventures, Red Abbey Venture Partners, Acidophil and Domain Associates, and 4 more on record.
United States · Funded startup
4 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$28Mraised across 4 rounds since 2008, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $1.6M sold, first sale Jan 2013
Reported by finance.yahoo.comSEC filing: $13M sold, first sale Jun 2010
Reported by venturedeal.com
Reported by findarticles.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Corridor Pharmaceuticals's investors include Quaker Partners, MedImmune Ventures, Red Abbey Venture Partners, Acidophil and Domain Associates, and 4 more on record.
Corridor Pharmaceuticals has raised $28M across 4 rounds since 2008.
Corridor Pharmaceuticals's most recent round was a Debt of $1.6M in Jan 2013.
Corridor Pharmaceuticals's largest round on record is $13M (Series A), in Jun 2010.
Corridor Pharmaceuticals's first round on record, in Oct 2008, was backed by Quaker Partners, MedImmune Ventures and Red Abbey Venture Partners and 1 others.
Corridor Pharmaceuticals's latest named round is a Debt, in Jan 2013.
Corridor Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.